Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Timing matters in budgeting. This section outlines indicators for when to revisit and tweak your budget to reflect new expenses.
18,658 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Investors often face a choice between a focused domestic REIT sleeve and broad international exposure. This article b...
When policymakers hint at rate moves, investors scramble to reprice risk. This guide breaks down how an evolving inte...
A new Roundhill ETF is turning heads with a heavyweight position in Micron Technology. This article explains what the...
As AI accelerates, the question on many investors' minds is will Nvidia stock soar. This article breaks down the driv...
A growing scam uses Bitcoin ATMs to pressure victims into sending crypto. San Antonio is posting bilingual warnings d...
As Buffett retires, Greg Abel takes the helm. Yet Berkshire’s quieter stock picker is delivering. This story breaks d...
Four buyers claim they paid an ex-NBA player for paintings, commissions, and jerseys that never arrived. This caution...
Investing in builders requires more than chasing growth. This deep dive unpacks why dream finders homes: promising st...
When planet labs stock popped today, traders looked for catalysts in a market that often overreacts to headlines. Thi...
Looking for steady income in a volatile market? This rock-solid dividend stock offers a 5%+ yield with durable payout...
After an 11% drop, investors wonder if CoreWeave stock can rebound. This article weighs the bull and bear cases, what...